Results 151 to 160 of about 433,122 (304)

New Onset of Fibromyalgia After Exposure to a Combat Environment: A Longitudinal Cohort Study

Arthritis Care &Research, Accepted Article.
Objective Traumatic life events are hypothesized to be triggers for the onset of fibromyalgia. Posttraumatic stress disorder (PTSD) is a common comorbidity of fibromyalgia. However, limited prospective data are available on the development of fibromyalgia after exposure to high magnitude stress.
Jay B. Higgs, Willie J. Hale, Casey L. Straud, Jim Mintz, Stacey Young‐McCaughan, Kimberly D. Gomes, Chelsea J. Sterne, Katrina M. Lawrence‐Wolff, Alan J. Bartholomew, Kevin M. Kelly, Douglas M. Maurer, Catherine Vriend, Brett T. Litz, Douglas E. Williamson, Alan L. Peterson, for the STRONG STAR Consortium   +15 more
wiley   +1 more source

A Giant Baker's Cyst in a Patient With Rheumatoid Arthritis: An Unusual Case. [PDF]

Cureus
Monteiro I, Sarria R, Moreira Pinheiro G, Môço R.   +3 more
europepmc   +1 more source

Periodontitis exposure within one year before anti-diabetic treatment and the risk of rheumatoid arthritis in diabetes mellitus patients: a population-based cohort study

, 2014
Hsin‐Hua Chen, Der-Yuan Chen, Shih-Yi Lin, Kuo‐Lung Lai, Yi‐Ming Chen, Yiing‐Jenq Chou, Pesus Chou, Ching‐Heng Lin, Nicole Huang   +8 more
openalex   +1 more source

THU0124 Occupational exposure to asbestos and risk of rheumatoid arthritis [PDF]

, 2017
Anna Ilar, Per Gustavsson, Pernilla Wiebert, Christine Bengtsson, Lars Klareskog, Lars Alfredsson   +5 more
openalex   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐modifying Antirheumatic Drug

Arthritis Care &Research, Accepted Article.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD) Methods PrismRA incorporated 19 gene expression features and 4 clinical features to assess a patient's likelihood of ...
Fenglong Xie, Timothy Beukelman, Nicholas P McCormick, Jeffrey R Curtis   +3 more
wiley   +1 more source

Long-term outcomes in seronegative rheumatoid arthritis. [PDF]

Arthritis Care Res (Hoboken)
Kimbrough BA, George RJ, Crowson CS, Achenbach SJ, Atkinson EJ, Kronzer VL, Davis JM, Myasoedova E.   +7 more
europepmc   +1 more source

Synergistic Osteogenesis After Co‐Administration of cmRNAs Encoding BMP‐2 and BMP‐7 Utilizing a Transcript‐Activated Matrix

Advanced Functional Materials, EarlyView.
This study demonstrates that the dual delivery of BMP‐2/‐7 coding cmRNAs for bone healing is demonstrated as feasible, safe, and highly osteogenic. Compared to single BMP‐2 or BMP‐7 cmRNAs, the combination enhances the production of both mineral and organic components of the extracellular matrix when delivered using a collagen‐HA scaffold, supporting ...
Claudia Del Toro Runzer, Joanna M. Sadowska, Nadia Roumans, Christian Plank, Christopher H. Evans, Fergal J. O'Brien, Martijn van Griensven, Elizabeth R. Balmayor   +7 more
wiley   +1 more source

Physician global assessment in rheumatoid arthritis-is there any logic? [PDF]

Rheumatol Adv Pract
Jäppinen K, Muilu P, Autio R, Kuusalo L, Sihvonen S, Sokka-Isler T, Rantalaiho V.   +6 more
europepmc   +1 more source

Estimation of Pentraxin 3 and Porphyromonas Gingivalis Levels in Patients with Rheumatoid Arthritis and Periodontitis- An Observational Study

, 2017
Shankar Gittaboyina
openalex   +1 more source

REACTIVATION OF BRUCELLOSIS AND RHEUMATOID ARTHRITIS IN PREGNANCY

, 2021
Odgerel Chimed‐Ochir
openalex   +2 more sources